期刊文献+

基质金属蛋白酶-2和血管内皮生长因子在喉癌中的表达及意义 被引量:8

Expressions of MMP-2 and VEGF in laryngeal carcinoma and their clinicopathology meanings
下载PDF
导出
摘要 目的探讨基质金属蛋白酶-2(MMP-2)和血管内皮生长因子(VEGF)在喉癌中的表达情况及临床意义。方法在全自动图像分析仪下采用免疫组化方法分别检测经临床及病理证实的54例喉癌、23例声带息肉和15例喉部正常黏膜组织的MMP-2、VEGF表达情况。结果喉癌组织中MMP-2的表达率为72.22%(39/54),与声带息肉(47.83%)和喉部正常黏膜组织(40.00%)比较,差异有统计学意义(P<0.05)。VEGF在喉癌中的表达率为70.37%(38/54),与声带息肉(39.13%)和喉部正常黏膜组织(46.67%)比较,差异有统计学意义(P<0.05)。MMP-2、VEGF的表达与喉癌的临床分期、淋巴结转移及浸润深度均有一定相关性。结论 MMP-2和VEGF可能共同参与喉癌的浸润和转移,与肿瘤的侵袭性生长有一定的关系。 Objective To study the expressions of matrix metalloproteinase-2(MMP-2)and vascular endothelial growth factor (VEGF)in laryngeal carcinoma and their clinicopathological significance.Methods The immuno-histochemical technique was used to detect the expression staining results of MMP-2 and VEGF in 54 cases of laryngeal carcinoma,23 cases of polyps of vocal cord and 1 5 cases of normal laryngeal mucous tissues verified by clinicopathology under the automatic image analyzer.Results The ex-pression rates of MMP-2 and VEGF were 72.22%(39/54)and 70.37%(38/54)in the laryngeal carcinoma tissue,which were sig-nificantly higher than 47.83% and 39.13% in polyps of vocal cord and 40.00% and 46.67% in the normal laryngeal tissues respec-tively,the differences between them had statistical significance(P〈0.05).The expressions of MMP-2 and VEGF had certain corre-lation with the clinical stage,lymph node metastasis and.infiltration depth of laryngeal carcinoma.Conclusion MMP-2 and VEGF may jointly participate in the process of infiltration and metastasis in laryngeal and have certain relation with the tumorous invasive growth.
出处 《重庆医学》 CAS CSCD 北大核心 2014年第16期1972-1974,共3页 Chongqing medicine
基金 云南省教育厅科学研究基金资助项目(2011C077) 昆明医学院第二附属医院联邦中青年医药师培养基金资助项目(2011-LB-01)
关键词 基质金属蛋白酶-2 血管内皮生长因子 喉肿瘤 免疫组化 matrix metatloproteinase 2 vascular endothelial growth factor laryngeal carcinoma immuno-histochemistry
  • 相关文献

参考文献15

  • 1林雁,张京晶,冯骏,刘世喜.内皮素A受体拮抗剂在人喉癌种植瘤的实验研究[J].华西医学,2009,24(10):2674-2676. 被引量:4
  • 2Johanna MP, Kirsi MR, Vesa VK, et al. Expression of ma trix metalloproteinase (MMP) 2 and MMP-2 in breast cancer with a special reference to activator protein-2, HER2, and prognosis[J]. Clinical Cancer Research, 2004, 10(22) : 7621-7628.
  • 3Kitadai Y, Haruma K,Tokutomi T. Significance of vessel count and vascular endothelial growth factor in human e- sophageal carcinomas [J ]. Clin Cancer Res, 1998,4 (9) : 2195-2200.
  • 4Partyka R,Gonciarz M,Jalowiecki P,et al. VEGF and metal- loproteinase-2 (MMP-2) expression in gastric cancer tissue [J]. Med Sei Monit,2012,18(4) :130-134.
  • 5Akhavan MM, Karimi M, Ghodrati M, et al. AT1 recep- tors activation enhances the expression of MMP-2, MMP- 13 and VEGF but not MMP-9 in B16F10 melanoma ceils[J]. Pak J Biol Sci,2011,14(17):821-830.
  • 6Desch A, Strozyk EA,Bauer A2F, et al. Highly invasive mela- noma ceils activate the vascular endothelium via an MMP-2/ integrin alphavbeta5 induced secretion of VEGF A[J]. Am J Pathol,2012,181(2) :693- 705.
  • 7Adya R, Tan BK, Punn A, et al. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis[J]. Cardiovasc Res, 2008,78 (2) :356-365.
  • 8Misra S,Fu AA,Puggioni A, et al. Increased shear stress with upregulation of VEGF-A and its receptors and MMP-2,MMP-9, and TIMP 1 in venous stenosis of he modialysis grafts[J]. Am J Physiol Heart Circ Physiol, 2008,294(5) :H2219-2230.
  • 9Tian X, Cong M, Zhou W, et al. Relationship between pro- tein expression of VEGF-C,MMP-2 and lymph node me- tastasis in papillary thyroid cancer[J]. J Int Med Res, 2008,36(4) :699- 703.
  • 10Doyle JL, Haas TL. Differential role of beta-catenin in VEGF and histamine-induced MMP-2 production in microvascular endothelial cells[J]. J Cell Biochem, 2009,107 (2) : 272-283.

二级参考文献10

  • 1汪宏波,王泽华,林美华.上皮性卵巢癌细胞凋亡指数和肿瘤微血管密度与肿瘤复发的关系[J].中国实用妇科与产科杂志,2005,21(3):163-165. 被引量:6
  • 2SALANI D, TARABOLETTI G, ROSANO L. Endothelin-1 induces an angiogenie phenotype in cultured endothelial cells and stimulates neovascularization in vivo [J]. Am J Pathol,2000,157 (5) :1703-1711.
  • 3LIANG J T, HUANG K C, JENG Y M. Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer[J]. Br J Surg, 2004,91 (3) : 355-361.
  • 4ROSANO L, DI CASTRO V, SPINELLA F. Combined targeting of endothelin a receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity[J]. Cancer Res,2007,67(13):6351-6359.
  • 5MAI H Q, ZENG Z Y, FENG K T. Therapeutic targeting of the endothelin a receptor in human nasopharyngeal carcinoma[J]. Cancer Sci,2006,97(12): 1388-1395.
  • 6FISCHGRABE J, GOTTE M, SMOLI.ICH M, et al. Impact of VEGF on the expression of the endothelin axis in human breast cancer cell lines[J]. Onkologie,2008,31(Suppl 1):31-32.
  • 7KITADAI Y, HARUMA K, TOKUTOMI T. Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas[J]. Clin Cancer Res,1998,4(9):2195-2200.
  • 8OKUDA Y, TSURUMARU K, SUZUK S, et al. Hypoxia and endothelin-1 induce VEGF production in human vascular smooth muscle cells[J]. Life Sci, 1998,63(6):477-484.
  • 9ROSANO L, DI CASTRO V, SPINELLA F. Combined targeting of endothelin a receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity[J]. Cancer Res, 2007,67(13) :6351-6359.
  • 10贾刚,张为民.内皮素-1促肿瘤血管新生机制[J].现代肿瘤医学,2009,17(1):165-168. 被引量:8

共引文献3

同被引文献58

引证文献8

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部